Int J Radiat Oncol Biol Phys 2023 Jul 1
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus.
Related Questions
Patient has multiple adverse features on pathology, however, PSA just became detectable one year after surgery. SPPORT included patients with PSA>0...
New answer by Radiation Oncologist at Memorial Sloan Kettering Cancer Center (April 17, 2024)
Agree with many of the comments above. I would consider adding ADT for detectable PSA <0.1 in patients with pT4, pN+, or GG5 disease who were under-represented or ineligibl...